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Accepted 26 April 2011A healthy 40-year-old, gravida 2, para 0 woman underwent
amniocentesis at 18 weeks of gestation because of her advanced
maternal age. Cytogenetic analysis revealed a karyotype of
46,XX in 25 colonies of cultured amniocytes. She underwent
repeated amniocentesis for investigation of genomic imbalance
in the fetus at 23 weeks of gestation because of intrauterine
growth restriction (IUGR). The biparietal diameter was 4.9 cm
(<3rd centile), the abdominal circumference was 14 cm
(<3rd centile), and the femur length was 2.6 cm (<3rd centile).
Oligonucleotide-based array comparative genomic hybridiza-
tion (aCGH) analysis using CytoChip Oligo (BlueGnome,
Cambridge, UK) array showed that uncultured amniocytes had
a small genomic gain in chromosome 2, consistent with the
diagnosis of trisomy 2 mosaicism, whereas cultured amniocytes
did not manifest any genomic imbalance in chromosome 2
(Fig. 1). Cytogenetic analysis of the cultured amniocytes
revealed a karyotype of 46,XX in all 19 observed colonies.
Interphase fluorescence in situ hybridization study of uncul-
tured amniocytes showed three signals of chromosome 2q11.1-
specific probe (RP11-468G5) (spectrum green) in 6 of 50 cells
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doi:10.1016/j.tjog.2011.07.01150) mosaicism for trisomy 2 in uncultured amniocytes (Fig. 2).
Level II ultrasound of the fetus at 24 weeks of gestation
revealed severe IUGR, decreased amount of amniotic fluid, and
clinodactyly of the hands. The biparietal diameter was 5.1 cm
(<3rd centile), the femur length was 2.9 cm (<3rd centile), the
abdominal circumference was 15.2 cm (<3rd centile), and the
amniotic fluid index was 9.4 cm. At 26 weeks of gestation,
a 448-g growth-restricted fetus was delivered with low-set ears,
macroglossia, clenched hands, and neonatal death. Conven-
tional cytogenetic analysis revealed karyotypes of 47,XX,þ2
[15]/46,XX[35] in amnion (Fig. 3); 46,XX (60 cells) in
umbilical cord; and 46,XX (100 cells) in blood. The cultures of
placenta and skin were not successful. aCGH analysis showed
that the skin and blood had no genomic imbalance in chromo-
some 2; amnion had a small genomic gain in chromosome 2,
consistent with the diagnosis of mosaic trisomy 2; and placenta
had a complete genomic gain in chromosome 2, consistent with
the diagnosis of trisomy 2 (Fig. 1). Quantitative fluorescent
polymerase chain reaction analysis of different sampling tissues
using polymorphic DNA markers revealed a diallelic pattern
with unequal biparental inheritance of chromosome 2 in amnion
and placenta and a diallelic pattern with equal biparental
inheritance of chromosome 2 in skin and umbilical cord. The
tissue of placenta had a dosage ratio of 2:1 (maternal allele:-
paternal allele), consistent with the diagnosis of trisomy 2, and
the tissue of amnion had a dosage ratio of 1.5:1 (maternal
allele:paternal allele), consistent with the diagnosis of mosaiccs & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
Fig. 1. Oligonucleotide-based array comparative genomic hybridization demonstrates that uncultured amniocytes (A) and amnion (B) had a small genomic gain in
chromosome 2; cultured amniocytes (C), blood (D), and skin (E) do not have any genomic gain in chromosome 2; and placenta (F) had a complete gain in
chromosome 2.
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the paternal allele dosage, indicating a maternal origin of the
trisomy 2 cell line. The results of quantitative fluorescent
polymerase chain reaction excluded uniparental disomy (UPD)
2 in the fetus.
The present case provides evidence for discrepant cytoge-
netic findings of mosaic trisomy 2 between uncultured and
cultured amniocytes, with uncultured amniocytes being posi-
tive for trisomy 2 by aCGH and interphase fluorescence in situ
hybridization, and cultured amniocytes being negative for
trisomy 2 by aCGH and conventional karyotyping. In the
present case, molecular cytogenetic analyses showed that the
tissues of placenta had trisomy 2, the tissues of amnion had
mosaic trisomy 2, the tissues of skin and blood of the fetus had
biparental disomy 2, the uncultured amniocytes had mosaictrisomy 2, and the cultured amniocytes had disomy 2. It is
likely that the fetus had biparental disomy 2; the amnion had
mosaic trisomy 2; the placenta had trisomy 2; and the uncul-
tured amniocytes contained amnion epithelium-origin trisomy
2 amniocytes, which disappeared after long-term culture. Our
observation was in accordance with the hypothesis of origin of
amnion in mosaicism raised by Robinson et al [1]. A trisomic
rescue occurs relatively late in the development, which causes
a few cells of the inner cell mass to be diploid, resulting in
cytogenetic discrepancies among placenta, amnion, and the
fetus, and an efficient selection against the trisomic cells when
biparental disomy is present.
The present case had complete trisomy 2 in placenta, mosaic
trisomy 2 in amnion, and disomy 2 in the fetus, and was asso-
ciated with severe IUGR and relative oligohydramnios. High
Fig. 3. A karyotype of 47,XX,þ2.
Fig. 2. Fluorescence in situ hybridization analysis of uncultured interphase amniocytes using bacterial artificial chromosome probes RP11-468G5 (2q11.1)
(spectrum green) and RP11-299N13 (8q11.1) (spectrum red) (internal control) shows (A) three green signals in a cell with trisomy 2 and (B) two green signals in
a cell with disomy 2. The result is consistent with the diagnosis of mosaic trisomy 2.
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well known to be associated with IUGR, oligohydramnios, and
adverse fetal outcome. For instance, Hansen et al [2] reported
maternal UPD in a diploid fetus and confined high levels of
mosaic trisomy 2 in placenta in a pregnancy with IUGR, oli-
gohydramnios, and fetal hypospadias. Roberts et al [3] reported
trisomy 2 at chorionic villus sampling (CVS), mosaic trisomy 2
(8 of 90 cells) at amniocentesis, biparental disomy 2 in amniotic
fluid and the fetus in a pregnancy with IUGR and neonatal
death. Sifakis et al [4] reported complete trisomy 2 at CVS and
mosaic trisomy 2 (1 of 53 cells) at amniocentesis in a pregnancy
with severe IUGR, oligohydramnios, and absent end-diastolic
flow in the fetus. IUGR may occur in high levels of trisomy 2or complete trisomy 2 in placenta with the presence [2,5,6] or
absence of fetal UPD 2 [3,7e10]. Robinson et al [1] additionally
suggested that the presence of trisomy 2 in amnion correlates
with poor pregnancy outcome even when the fetus carries
diploid cells.
Sifakis et al [4] previously suggested that the presence of
trisomy 2 in CVS cultures may not require further investi-
gation by amniocentesis. However, our presentation shows
that, in instances of trisomy 2 diagnosed by CVS, further
investigation by amniocentesis using molecular cytogenetic
technologies on both uncultured and cultured amniocytes is
useful for our understanding of possible fetal and amniotic
involvement.
Fig. 4. Representative electrophoretograms of quantitative fluorescent poly-
merase chain reaction assays. The marker D2S1364 shows two peaks
(126 bp:130 bp; maternal and paternal, respectively) of unequal fluorescent
activity from two different parental alleles in the tissues of amnion with
a dosage ratio of 1.5:1 (maternal:paternal) and in the tissues of placenta with
a dosage ratio of 2:1 (maternal:paternal). (A) Father; (B) mother; (C) amnion;
and (D) placenta.
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